Nvidia's $4 Trillion Data Center Vision Dances Between a Denied SpaceX Rumor and a Pharma AI Factory
Published on 07/20/2026 at 22:03 | Redaktion boerse-global.de
Jensen Huang wants investors to look past the daily noise and fix their eyes on a breathtaking horizon: global data center spending that could hit $4 trillion annually by 2030. That long-range thesis has kept Nvidia's story alive even as the stock drifted sideways in recent weeks. But on Monday, the narrative had to accommodate both a spectacular denial from Elon Musk and a concrete deal with a pharmaceutical heavyweight — a reminder that, for now, the market's attention remains pinned on the here and now.
Shares of Nvidia ended the session at €180.02 in Frankfurt, up 1.44% on the day, despite a report that Musk had dismissed as "fake news" the claim that SpaceX had ordered roughly one million GB300 chips from Foxconn in a $52 billion deal. The denial did little to derail the broader momentum. QumulusAI, a cloud provider, separately confirmed it had purchased 1,632 Nvidia Blackwell B300 chips to meet rising customer demand, and Bristol Myers Squibb announced it would build one of the most powerful AI factories in the life sciences sector using Nvidia's upcoming DGX Vera-Rubin NVL72 systems. The BMS deal is a multi-year expansion of an existing collaboration, and the new architecture promises up to ten times the performance per megawatt compared with current Blackwell systems.
The stock still sits 11.10% below its 52-week high of €202.50 hit in May, and the market cap stands at roughly €4.29 trillion. Technical readings reflect a market without clear direction: the 14-day relative strength index sits at 49.1, while annualized volatility of nearly 35% underscores the sector's jitters. Yet the long-term trend remains intact — the share price is 8.69% above its 200-day moving average of €165.63, and analysts on Wall Street are pushing their price targets higher even as the stock treads water. Bank of America lifted its goal to $350 from $320, maintaining its buy rating, while Morgan Stanley raised its target twice this year, most recently to $288. Analyst Joseph Moore cited strong demand for compute power but warned of competition from specialized chip designs.
Should investors sell immediately? Or is it worth buying Nvidia?
Nvidia is also widening its moat on the software side. At the SIGGRAPH conference, the company integrated its Omniverse libraries into its own Agent Toolkit, giving AI agents the ability to train and test in simulated 3D environments — a move designed to accelerate what it calls "Physical AI." Partners such as SideFX and PTC are already plugging the libraries into CAD and product data management workflows. The software push complements the hardware roadmap, and the Vera-Rubin architecture that BMS is betting on is seen as the next major product cycle.
The path to Huang's $4 trillion projection, however, is far from straight. China remains an open question: Nvidia has grown largely without meaningful chip sales to the country due to US export restrictions, and while a partial easing has raised hopes of a return, Beijing continues to erect its own barriers. A genuine recovery in Chinese demand would accelerate the growth trajectory, but for now it remains speculative. The next concrete test comes from the hyperscalers: Microsoft is due to report its fiscal fourth-quarter results this month, and its commentary on capital expenditure plans will offer the first real check on whether the trillion-dollar thesis is gaining traction. Nvidia itself reports fiscal second-quarter 2027 results on August 26, when investors will press for updates on Vera-Rubin production and any further relaxation of export curbs into regions like the United Arab Emirates.
Ad
Nvidia Stock: New Analysis - 20 July
Fresh Nvidia information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
